Treatment of Behçet Uveitis in Türkiye
Turkish Journal of Ophthalmology · 29.08.2024 · 198-204
DOI: 10.4274/tjo.galenos.2024.89346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Ophthalmology, online erschienen am 29.08.2024. Verfasst von Pınar Çakar Özdal und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences Türkiye, Ulucanlar Eye Training and Research Hospital, Clinic of Ophthalmology, Ankara, Türkiye. Hauptthemen laut MEDLINE: Behcet Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
Behçet uveitis (BU) is a potentially blinding disorder. The main determinant of visual prognosis is early and appropriate treatment that provides rapid suppression of inflammatory attacks, control of subclinical inflammation, and prevention of new attacks. Our study aimed to determine the Turkish uveitis specialists' approach regarding the treatment choices and management of special situations such as pregnancy, vaccination, and surgical planning in BU patients, and to increase information sharing and raise awareness of issues where knowledge is lacking. Materials and Methods: A web-based survey including 16 questions about the treatment approach in ocular involvement of Behçet's disease was sent via e-mail to uveitis specialists in Türkiye. Based on the answers of 49 ophthalmologists who responded to the survey, we evaluated the approaches of uveitis specialists in our country to initiating treatment, selecting therapeutic agents, monitoring, switching and stopping treatment, and special situations such as surgical planning, vaccination, and pregnancy in BU patients.
Results
Uveitis specialists in our country mostly act in accordance with the guidelines in the decision to start treatment, selection of therapeutic agents, and monitoring the safety of treatment in BU. However, there is a lack of information about the therapeutic approach in pregnancy and vaccination practices. It was also observed that there is no consensus on the precautions to be taken before cataract surgery.
Conclusion
Our study has shown that there is a need for more detailed and widespread information sharing on treatment in preparation for ocular surgery, safety monitoring, drug use during pregnancy, and vaccination in BU patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Health Sciences Türkiye, Ulucanlar Eye Training and Research Hospital, Clinic of Ophthalmology, Ankara, Türkiye.
- Ankara University Faculty of Medicine, Department of Ophthalmology, Ankara, Türkiye.
- University of Health Sciences Türkiye, Etlik City Hospital, Clinic of Ophthalmology, Ankara, Türkiye.
- Private Eye Clinic, Adana, Türkiye.
- İstanbul Bayrampaşa Eye Hospital, İstanbul, Türkiye.
ORCID-Profile: Pınar Çakar Özdal, Fatime Nilüfer Yalçındağ, Yasemin Özdamar Erol, Merih Soylu, İlknur Tuğal-Tutkun
Zitieren
APA
Çakar Özdal, P., Yalçındağ, F. N., Özdamar Erol, Y., Soylu, M., & Tuğal-Tutkun, İ. (2024). Treatment of Behçet Uveitis in Türkiye. Turkish Journal of Ophthalmology, 198-204. https://doi.org/10.4274/tjo.galenos.2024.89346
Vancouver
Çakar Özdal P, Yalçındağ FN, Özdamar Erol Y, Soylu M, Tuğal-Tutkun İ. Treatment of Behçet Uveitis in Türkiye. Turkish Journal of Ophthalmology. 2024:198-204. doi:10.4274/tjo.galenos.2024.89346
BibTeX
@article{akarzdal2024,
author = {Çakar Özdal, Pınar and Yalçındağ, Fatime Nilüfer and Özdamar Erol, Yasemin and Soylu, Merih and Tuğal-Tutkun, İlknur},
title = {Treatment of Behçet Uveitis in Türkiye},
journal = {Turkish Journal of Ophthalmology},
year = {2024},
pages = {198--204},
doi = {10.4274/tjo.galenos.2024.89346}
}
EUVIMED